Transdermal Ultrasound Surgery Market

Transdermal Ultrasound Surgery Market Overview

Transdermal drug delivery method suggests a lucrative alternative the traditional drug delivery method of injections as well as oral administration. Nevertheless, the outermost layer of the skin serves as an obstacle that controls the penetration of the macromolecular substances into the skin.

Application of Ultrasound irradiation on to the skin increases the permeability of macromolecules, and this enables the delivery of different substances into the skin and also through the skin. The use of ultrasound irradiation to deliver drugs through the skin is called as sonophoresis or phonophoresis. Ultrasound transdermal drug delivery system improves the current ways of drug deliveries such as regional, systemic and local drug delivery.

High-frequency sonophoresis use dates back to 1950s, and Low-Frequency Sonophoresis is checked during the last two decades. Furthermore, the high-frequency sonophoresis and low-frequency sonophoresis are similar as the both use ultrasound to enhance the penetration of drugs and macromolecules into the skin, though the mechanisms associated with each of the frequencies are different.

Also, the site of cavitation and the degree to which each procedure can increase the skin penetration are quite different.

Global Ultrasound Transdermal Drug Delivery Market - Market Dynamics

The most significant driver for the rapid development of the global Ultrasound Transdermal Drug Delivery market is the rising awareness of non-invasive drug delivery methods enhancing the Ultrasound Transdermal Drug Delivery market ahead. Also, the Ultrasound Transdermal Drug Delivery method is preferred more in situations which require medications to be injected many times either daily or weekly.

Ultrasound Transdermal Drug Delivery system’s advantages over the conventional drug delivery system also significantly affect the Ultrasound Transdermal Drug Delivery market. Major challenges faced by the Ultrasound Transdermal Drug Delivery market are the availability of such type of devices, the determination of the duration of treatment required; gaining a full understanding of how the technology functions; broadening of the range of drugs that can be delivered and evaluation of the safety profiles of the devices.

Global Ultrasound Transdermal Drug Delivery Market - Regional Outlook

Regionally, the Ultrasound Transdermal Drug Delivery market has been segmented into North America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, Latin America, and Middle East & Africa. Amid them, Europe and North America are the most dominating markets for the Ultrasound Transdermal Drug Delivery.

This is due to the high incidences of cardiovascular ailments and hormonal therapies observed in both the regions. The recent research and developments in the Ultrasound Transdermal Drug Delivery market are also opening new horizons for this market. Followed by North America and Europe, comes Asia Pacific concerning market share. The developing economies like India and China are major growth drivers of this market.

Increasing instances of pain, hormonal therapies, cardiovascular ailments and fast-developing healthcare infrastructure, along with the growth in the medical tourism, have roused the Ultrasound Transdermal Drug Delivery market. This region is going to witness highest CAGR during the forecast period.

Global Ultrasound Transdermal Drug Delivery Market - Major Players

Currently, the global Ultrasound Transdermal Drug Delivery market is highly competitive owing to the involvement of many established players and government policies. Some of the key players in the Global Ultrasound Transdermal Drug Delivery market areEcho Therapeutics, Franklin, MA,Iomed Incorporated, Salt Lake City, UT,Abbot Laboratories, Chicago, IL and many others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology, material and applications.

The report covers exhaustive analysis on

• Market Segments
• Market Dynamics
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Technology
• Value Chain

Regional analysis includes

• North America (U.S., Canada)
• Latin America (Mexico, Brazil, Argentina)
• Western Europe (Germany, Italy, U.K, Spain, France, Nordic, Rest of Western Europe)
• Eastern Europe (Russia, Poland)
• Asia Pacific (China, India, ASEAN, Australia & New Zealand)
• Japan
• Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Global Ultrasound Transdermal Drug Delivery Market - Segmentation

Based on the type of radiation, the Global Ultrasound Transdermal Drug Delivery market can be segmented into,

• High-Frequency Sonophoresis
• Low-Frequency Sonophoresis

By Indication, the Global Ultrasound Transdermal Drug Delivery market can be segmented into,

• CNS
• Pain Management
• Hormone
• Cardiovascular
• Others

By End User, the Global Ultrasound Transdermal Drug Delivery market can be segmented into

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers

By Region, the Global Ultrasound Transdermal Drug Delivery market can be segmented into,

• North America
• Western Europe
• Western Europe
• Asia Pacific Excluding Japan
• Japan
• Latin America
• Middle East & Africa